Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
273 participants
INTERVENTIONAL
2017-11-13
2019-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Efficacy, Safety and Injection Technique of Restylane Lip Volume and Restylane Lip Refresh
NCT01428024
Safety/Efficacy Study of Restylane® in Lip Augmentation
NCT00935272
Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
NCT02703948
Study to Evaluate Satisfaction After Treatment With Kysse
NCT03967444
Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects
NCT05342753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New Dermal Filler
hyaluronic acid
New Dermal Filler
hyaluronic acid
Dermal Filler
hyaluronic acid
Device: FDA Approved Dermal Filler
hyaluronic acid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
New Dermal Filler
hyaluronic acid
Device: FDA Approved Dermal Filler
hyaluronic acid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
* Seeking augmentation therapy for the lips
Exclusion Criteria
* Allergy or hypersensitivity to lidocaine or other amide-type anesthetics, or topical anesthetics or nerve blocking agents.
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Testing of Bevelry Hills
Encino, California, United States
Cosmetic Laser Dermatology
San Diego, California, United States
Art of Skin MD
Solana Beach, California, United States
Skin Research Institute, LLC
Coral Gables, Florida, United States
University of Miami
Miami, Florida, United States
Research Institute of SouthEast
West Palm Beach, Florida, United States
Atlanta Dermatology, Vein & Research Center, LLC
Alpharetta, Georgia, United States
Maryland Dermatology, Laser, Skin & Vein Institute
Hunt Valley, Maryland, United States
SkinCare Physicians
Chestnut Hill, Massachusetts, United States
BOYD
Birmingham, Michigan, United States
Laser & Skin Surgery Center of New York
New York, New York, United States
Aesthetic Solutions, PA
Chapel Hill, North Carolina, United States
Brian S. Biesman, MD
Nashville, Tennessee, United States
Center for Advanced Clinical Research
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
43USK1701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.